TP53 and neoplasm: The view that EGFR and TP53 mutations are initial events that drive early tumour progression is supported by several studies that demonstrate sequential increase in EGFR alterations9 and intra-nuclear accumulation of nonfunctional P53 protein throughout the AAH–AIS–MIA continuum45, 46.